Clinical Laboratory Improvement Advisory Committee, 48573-48574 [05-16432]

Download as PDF Federal Register / Vol. 70, No. 159 / Thursday, August 18, 2005 / Notices VI.2. Administrative and National Policy Requirements 45 CFR Part 74 and Part 92 For more information on the Code of Federal Regulations, see the National Archives and Records Administration at the following Internet address: https:// www.access.gpo.gov/nara/cfr/cfr-tablesearch.html. The following additional requirements apply to this project: • AR–4 HIV/AIDS Confidentiality Provisions. • AR–6 Patient Care. • AR–8 Public Health System Reporting Requirements. • AR–10 Smoke-Free Workplace Requirements. • AR–14 Accounting System Requirements. Applicants can find additional information on these requirements can be found on the HHS/CDC Web site at the following Internet address: https:// www.cdc.gov/od/pgo/funding/ARs.htm. You need to include an additional Certifications form from the PHS5161– 1 application in your Grants.gov electronic submission only. Please refer to https://www.cdc.gov/od/pgo/funding/ PHS5161-1-Certificates.pdf. Once you have filled out the form, please attach to the Grants.gov submission as Other Attachment Forms. VI.3. Reporting Requirements You must provide HHS/CDC with an original, plus two hard copies of the following reports: 1. Interim progress report, due no less than 90 days before the end of the budget period. The progress report will serve as your non-competing continuation application, and must contain the following elements: a. Current Budget Period Activities Objectives. b. Current Budget Period Financial Progress. c. New Budget Period Program Proposed Activity Objectives. d. Budget. e. Measures of Effectiveness, including progress against the numerical goals of the President’s Emergency Plan for AIDS Relief for Namibia. f. Additional Requested Information. 2. Annual progress report, due no more than 60 days after the end of the budget period. Reports should include progress against the numerical goals of the President’s Emergency Plan for AIDS Relief for Namibia. 3. Financial status report no more than 90 days after the end of the budget period. VerDate jul<14>2003 12:20 Aug 17, 2005 Jkt 205001 4. Final financial and performance reports, no more than 90 days after the end of the project period. Recipients must be mail these reports to the Grants Management or Contract Specialist listed in the ‘‘Agency Contacts’’ section of this announcement. VII. Agency Contacts We encourage inquiries concerning this announcement. For general questions, contact: Technical Information Management Section, CDC Procurement and Grants Office, U.S. Department of Health and Human Services, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770–488–2700. For program technical assistance, contact: Leonard Floyd, U.S. Department of State, U.S. Department of Health and Human Services, 2540 Windhoek Place, Washington, DC 20521–8320, Telephone: 011 264 61224 149, E-mail: Floydl@nacop.net. For financial, grants management, or budget assistance, contact: Shirley Wynn, Grants Management Specialist, CDC Procurement and Grants Office, U.S. Department of Health and Human Services, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770– 488–1515, E-mail: swynn@cdc.gov. VIII. Other Information Applicants can find this and other HHS funding opportunity announcements on the HHS/CDC Web site, Internet address: https:// www.cdc.gov. (Click on ‘‘Funding,’’ then ‘‘Grants and Cooperative Agreements’’), and on the Web site of the HHS Global Health Affairs, Internet address: https:// www.globalhealth.gov. Dated: August 11, 2005. William P. Nichols, Director, Procurement and Grants Office, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. [FR Doc. 05–16373 Filed 8–17–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Clinical Laboratory Improvement Advisory Committee In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 48573 Name: Clinical Laboratory Improvement Advisory Committee (CLIAC). Times and Dates: 8:30 a.m.–5 p.m., September 7, 2005. 8:30 a.m.–3 p.m., September 8, 2005. Place: Doubletree Hotel (Atlanta/ Buckhead), 3342 Peachtree Rd. NE., Atlanta, Georgia 30326, Telephone: (404) 231–1234. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This committee is charged with providing scientific and technical advice and guidance to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the need for, and the nature of, revisions to the standards under which clinical laboratories are regulated; the impact on medical and laboratory practice of proposed revisions to the standards; and the modification of the standards to accommodate technological advances. Matters To Be Discussed: The agenda will include updates from the Food and Drug Administration, the Centers for Medicare & Medicaid Services, and the Centers for Disease Control and Prevention; reports on the Institute for Quality in Laboratory Medicine, investigation and recommendations concerning proficiency testing for infectious diseases, status of cytology proficiency testing; and, presentations and discussion regarding appropriate quality control for diverse and evolving test systems and marketing the Good Laboratory Practices for Waived Testing Sites guidelines. Agenda items are subject to change as priorities dictate. Providing Oral or Written Comments: It is the policy of CLIAC to accept written public comments and provide a brief period for oral public comments whenever possible. Oral Comments: In general, each individual or group requesting to make an oral presentation will be limited to a total time of five minutes (unless otherwise indicated). Speakers must also submit their comments in writing for inclusion in the meeting’s Summary Report. To assure adequate time is scheduled for public comments, individuals or groups planning to make an oral presentation should, when possible, notify the contact person below at least one week prior to the meeting date. Written Comments: For individuals or groups unable to attend the meeting, CLIAC accepts written comments until the date of the meeting (unless otherwise stated). However, the comments should be received at least one week prior to the meeting date so that the comments may be made available to the Committee for their consideration and public distribution. Written comments, one hard copy with original signature, should be provided to the contact person below. Written comments will be included in the meeting’s Summary Report. Contact Person For Additional Information: Rhonda Whalen, Chief, Laboratory Practice Standards Branch, Division of Public Health Partnerships— Laboratory Systems, National Center for Health Marketing, Coordinating Center for Health Information and Service, CDC, 4770 E:\FR\FM\18AUN1.SGM 18AUN1 48574 Federal Register / Vol. 70, No. 159 / Thursday, August 18, 2005 / Notices Buford Highway, NE., Mailstop F–11, Atlanta, Georgia 30341–3717; telephone (770)488–8042; fax (770)488–8279; or via email at RWhalen@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for CDC and the Agency for Toxic Substances and Disease Registry. Dated: August 15, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–16432 Filed 8–17–05; 8:45 am] BILLING CODE 4163–18–P Dated: August 12, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–16359 Filed 8–17–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [CGD05–05–085] Implementation of Sector Hampton Roads Coast Guard, DHS. Notice of organizational change. AGENCY: ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Epidemiologic Study of Inflammatory Bowel Disease, Request for Applications Number DP– 05–130 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Epidemiologic Study of Inflammatory Bowel Disease, Request for Applications Number DP–05–130. Time and Date: 1 p.m.–3 p.m., September 23, 2005 (Closed). Place: Teleconference. Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to: Epidemiologic Study of Inflammatory Bowel Disease, Request for Applications Number DP–05–130. Contact Person For More Information: J. Felix Rogers, PhD, MPH, Scientific Review Administrator, National Center for Chronic Disease Prevention and Health Promotion, 4770 Buford Highway, MS–K92, Atlanta, GA 30341, Telephone (404) 639–6101. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate jul<14>2003 12:20 Aug 17, 2005 Jkt 205001 SUMMARY: The Coast Guard announces the stand-up of Sector Hampton Roads and its subordinate unit, Sector Field Office (SFO) Eastern Shore. Sector Hampton Roads is subordinate to the Fifth Coast Guard District Commander. The Sector Hampton Roads Commander has the authority, responsibility, and missions of the prior Group Hampton Roads Commander, Commanding Officer Marine Safety Office Hampton Roads, Captain of the Port (COTP), Officer in Charge, Marine Inspection (OCMI), Federal on Scene Coordinator (FOSC), Federal Maritime Security Coordinator (FMSC), and Search and Rescue Mission Coordinator (SMC). The Deputy Sector Commander is designated alternate COTP, FMSC, FOSC, SMC and Acting OCMI. The Deputy Sector Commander also assumes active search suspension (ACTSUS) authority in the absence of the Sector Commander. The Commander of SFO Eastern Shore is subordinate to the Sector Commander and is vested with all the rights, responsibilities, duties, and authority of a Group Commander, which includes SMC. In the absence of the SFO Commander, SMC authority may remain with the Acting Commander. However, active search suspension (ACTSUS) authority will revert to the Commander, Sector Hampton Roads. A continuity of operations order has been issued ensuring that all previous MSO Hampton Roads, Group Hampton Roads, and Group Eastern Shore practices and procedures will remain in effect until superseded by an authorized Coast Guard official and/or document. This continuity of operations order addresses existing COTP regulations, orders, directives and policies. DATES: This change was effective July 15, 2005. PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 Documents indicated in this preamble as being available in the docket are part of docket CGD05–05– 085 and are available for inspection or copying at Fifth District Marine Safety Division, 431 Crawford Street, Portsmouth, VA 23704 between 7:30 a.m. and 4:30 p.m., Monday through Friday, except Federal Holidays. FOR FURTHER INFORMATION CONTACT: Commander Brian Hall, Fifth District Marine Safety Division at 757–398– 6520. SUPPLEMENTARY INFORMATION: Sector Hampton Roads is located at 4000 Coast Guard Blvd., Portsmouth, VA 23703– 2199. A command center supporting Sector Hampton Roads is located at Portsmouth, VA. A second command center operated by SFO Eastern Shore will support the SFO and the SFO’s subordinate units along the Delmarva Peninsula in Delaware, Maryland, and Virginia. Sector Hampton Roads is composed of a Response Department, Prevention Department, and Logistics Department. All existing missions and functions performed by Marine Safety Office Hampton Roads, Group Hampton Roads, and Group Eastern Shore have been realigned under this new organizational structure as of July 15, 2005. MSO Hampton Roads, Groups Hampton Roads, and Group Eastern Shore no longer exist as organizational entities. The boundary of the Sector Hampton Roads Marine Inspection, Captain of the Port Zone, and SMC Area of Responsibility (AOR) is as follows: ‘‘Beginning at the intersection of the Maryland-Delaware boundary and the coast at Fenwick Island and proceeds along the Maryland-Delaware boundary to a point 75 degrees 30.0 minutes W. longitude; thence southerly to a point 75 degrees 30.0 minutes W. longitude on the Maryland-Virginia boundary, thence westerly along the Maryland-Virginia boundary as it proceeds across the Delmarva Peninsula, Pocomoke River, Tangier and Pocomoke Sounds, and Chesapeake Bay; thence northwesterly along the Maryland-Virginia boundary as those boundaries are formed along the southern bank of the Potomac river to the intersection of Prince William County, Virginia; thence northwestwardly along the Prince William County, Virginia boundary to the intersection of Loudon County, Virginia; thence westward following the Loudon County, Virginia boundary to the intersection with Clarke County, Virginia; thence northeasterly following the Loudon County boundary to the intersection of the Clark County, Virginia-West Virginia boundaries; thence northwestward along the ADDRESSES: E:\FR\FM\18AUN1.SGM 18AUN1

Agencies

[Federal Register Volume 70, Number 159 (Thursday, August 18, 2005)]
[Notices]
[Pages 48573-48574]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16432]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Clinical Laboratory Improvement Advisory Committee 
(CLIAC).
    Times and Dates:

8:30 a.m.-5 p.m., September 7, 2005.
8:30 a.m.-3 p.m., September 8, 2005.

    Place: Doubletree Hotel (Atlanta/Buckhead), 3342 Peachtree Rd. 
NE., Atlanta, Georgia 30326, Telephone: (404) 231-1234.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact on medical and laboratory practice of proposed revisions to 
the standards; and the modification of the standards to accommodate 
technological advances.
    Matters To Be Discussed: The agenda will include updates from 
the Food and Drug Administration, the Centers for Medicare & 
Medicaid Services, and the Centers for Disease Control and 
Prevention; reports on the Institute for Quality in Laboratory 
Medicine, investigation and recommendations concerning proficiency 
testing for infectious diseases, status of cytology proficiency 
testing; and, presentations and discussion regarding appropriate 
quality control for diverse and evolving test systems and marketing 
the Good Laboratory Practices for Waived Testing Sites guidelines.
    Agenda items are subject to change as priorities dictate.
    Providing Oral or Written Comments: It is the policy of CLIAC to 
accept written public comments and provide a brief period for oral 
public comments whenever possible. Oral Comments: In general, each 
individual or group requesting to make an oral presentation will be 
limited to a total time of five minutes (unless otherwise 
indicated). Speakers must also submit their comments in writing for 
inclusion in the meeting's Summary Report. To assure adequate time 
is scheduled for public comments, individuals or groups planning to 
make an oral presentation should, when possible, notify the contact 
person below at least one week prior to the meeting date. Written 
Comments: For individuals or groups unable to attend the meeting, 
CLIAC accepts written comments until the date of the meeting (unless 
otherwise stated). However, the comments should be received at least 
one week prior to the meeting date so that the comments may be made 
available to the Committee for their consideration and public 
distribution. Written comments, one hard copy with original 
signature, should be provided to the contact person below. Written 
comments will be included in the meeting's Summary Report.
    Contact Person For Additional Information: Rhonda Whalen, Chief, 
Laboratory Practice Standards Branch, Division of Public Health 
Partnerships--Laboratory Systems, National Center for Health 
Marketing, Coordinating Center for Health Information and Service, 
CDC, 4770

[[Page 48574]]

Buford Highway, NE., Mailstop F-11, Atlanta, Georgia 30341-3717; 
telephone (770)488-8042; fax (770)488-8279; or via e-mail at 
RWhalen@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for CDC and the Agency for Toxic Substances and Disease 
Registry.

    Dated: August 15, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-16432 Filed 8-17-05; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.